Clinical Trial Update: Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target Trough Attainment While Minimizing High Exposures That Impose Increased Risk of Side Effects Such as Hyperammonemia

View source ↗

Summary

This clinical trial sub-study aims to develop a pharmacokinetic model for Erwinase (L-asparaginase from Erwinia chrysanthemi) to optimize trough levels while re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Erwinase (L-asparaginase from Erwinia chrysanthemi)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Acute Lymphoblastic Leukemia | Status: RECRUITING